Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition

Nick P. van Goethem, Dean Paes, Daniela Puzzo, Ernesto Fedele, Claudia Rebosio, Walter Gulisano, Agostino Palmeri, Lawrence P. Wennogle, Youyi Peng, Daniel Bertrand, Jos Prickaerts

Research output: Contribution to journalArticle

Abstract

α7 nicotinic acetylcholine receptors (α7nAChRs) have been targeted to improve cognition in different neurological and psychiatric disorders. Nevertheless, no α7nAChR activating ligand has been clinically approved. Here, we investigated the effects of antagonizing α7nAChRs using the selective antagonist methyllycaconitine (MLA) on receptor activity in vitro and cognitive functioning in vivo. Picomolar concentrations of MLA significantly potentiated receptor responses in electrophysiological experiments mimicking the in vivo situation. Furthermore, microdialysis studies showed that MLA administration substantially increased hippocampal glutamate efflux which is related to memory processes. Accordingly, pre-tetanus administration of low MLA concentrations produced longer lasting potentiation (long-term potentiation, LTP) in studies examining hippocampal plasticity. Moreover, low doses of MLA improved acquisition, but not consolidation memory processes in rats. While the focus to enhance cognition by modulating α7nAChRs lies on agonists and positive modulators, antagonists at low doses should provide a novel approach to improve cognition in neurological and psychiatric disorders.

Original languageEnglish
Article number109338
JournalCellular Signalling
Volume62
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Nicotinic Receptors
Cognition
Nervous System Diseases
Psychiatry
Long-Term Potentiation
Microdialysis
Tetanus
Glutamic Acid
methyllycaconitine
Ligands

Keywords

  • Antagonist
  • Ligand-gated ion channel
  • Long-term potentiation
  • Memory acquisition
  • Receptor activity
  • α7 nicotinic acetylcholine receptors

ASJC Scopus subject areas

  • Cell Biology

Cite this

Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition. / van Goethem, Nick P.; Paes, Dean; Puzzo, Daniela; Fedele, Ernesto; Rebosio, Claudia; Gulisano, Walter; Palmeri, Agostino; Wennogle, Lawrence P.; Peng, Youyi; Bertrand, Daniel; Prickaerts, Jos.

In: Cellular Signalling, Vol. 62, 109338, 01.10.2019.

Research output: Contribution to journalArticle

van Goethem, NP, Paes, D, Puzzo, D, Fedele, E, Rebosio, C, Gulisano, W, Palmeri, A, Wennogle, LP, Peng, Y, Bertrand, D & Prickaerts, J 2019, 'Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition', Cellular Signalling, vol. 62, 109338. https://doi.org/10.1016/j.cellsig.2019.06.003
van Goethem, Nick P. ; Paes, Dean ; Puzzo, Daniela ; Fedele, Ernesto ; Rebosio, Claudia ; Gulisano, Walter ; Palmeri, Agostino ; Wennogle, Lawrence P. ; Peng, Youyi ; Bertrand, Daniel ; Prickaerts, Jos. / Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition. In: Cellular Signalling. 2019 ; Vol. 62.
@article{c55bebda9d6b46558dc3e978edc272a1,
title = "Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition",
abstract = "α7 nicotinic acetylcholine receptors (α7nAChRs) have been targeted to improve cognition in different neurological and psychiatric disorders. Nevertheless, no α7nAChR activating ligand has been clinically approved. Here, we investigated the effects of antagonizing α7nAChRs using the selective antagonist methyllycaconitine (MLA) on receptor activity in vitro and cognitive functioning in vivo. Picomolar concentrations of MLA significantly potentiated receptor responses in electrophysiological experiments mimicking the in vivo situation. Furthermore, microdialysis studies showed that MLA administration substantially increased hippocampal glutamate efflux which is related to memory processes. Accordingly, pre-tetanus administration of low MLA concentrations produced longer lasting potentiation (long-term potentiation, LTP) in studies examining hippocampal plasticity. Moreover, low doses of MLA improved acquisition, but not consolidation memory processes in rats. While the focus to enhance cognition by modulating α7nAChRs lies on agonists and positive modulators, antagonists at low doses should provide a novel approach to improve cognition in neurological and psychiatric disorders.",
keywords = "Antagonist, Ligand-gated ion channel, Long-term potentiation, Memory acquisition, Receptor activity, α7 nicotinic acetylcholine receptors",
author = "{van Goethem}, {Nick P.} and Dean Paes and Daniela Puzzo and Ernesto Fedele and Claudia Rebosio and Walter Gulisano and Agostino Palmeri and Wennogle, {Lawrence P.} and Youyi Peng and Daniel Bertrand and Jos Prickaerts",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.cellsig.2019.06.003",
language = "English",
volume = "62",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition

AU - van Goethem, Nick P.

AU - Paes, Dean

AU - Puzzo, Daniela

AU - Fedele, Ernesto

AU - Rebosio, Claudia

AU - Gulisano, Walter

AU - Palmeri, Agostino

AU - Wennogle, Lawrence P.

AU - Peng, Youyi

AU - Bertrand, Daniel

AU - Prickaerts, Jos

PY - 2019/10/1

Y1 - 2019/10/1

N2 - α7 nicotinic acetylcholine receptors (α7nAChRs) have been targeted to improve cognition in different neurological and psychiatric disorders. Nevertheless, no α7nAChR activating ligand has been clinically approved. Here, we investigated the effects of antagonizing α7nAChRs using the selective antagonist methyllycaconitine (MLA) on receptor activity in vitro and cognitive functioning in vivo. Picomolar concentrations of MLA significantly potentiated receptor responses in electrophysiological experiments mimicking the in vivo situation. Furthermore, microdialysis studies showed that MLA administration substantially increased hippocampal glutamate efflux which is related to memory processes. Accordingly, pre-tetanus administration of low MLA concentrations produced longer lasting potentiation (long-term potentiation, LTP) in studies examining hippocampal plasticity. Moreover, low doses of MLA improved acquisition, but not consolidation memory processes in rats. While the focus to enhance cognition by modulating α7nAChRs lies on agonists and positive modulators, antagonists at low doses should provide a novel approach to improve cognition in neurological and psychiatric disorders.

AB - α7 nicotinic acetylcholine receptors (α7nAChRs) have been targeted to improve cognition in different neurological and psychiatric disorders. Nevertheless, no α7nAChR activating ligand has been clinically approved. Here, we investigated the effects of antagonizing α7nAChRs using the selective antagonist methyllycaconitine (MLA) on receptor activity in vitro and cognitive functioning in vivo. Picomolar concentrations of MLA significantly potentiated receptor responses in electrophysiological experiments mimicking the in vivo situation. Furthermore, microdialysis studies showed that MLA administration substantially increased hippocampal glutamate efflux which is related to memory processes. Accordingly, pre-tetanus administration of low MLA concentrations produced longer lasting potentiation (long-term potentiation, LTP) in studies examining hippocampal plasticity. Moreover, low doses of MLA improved acquisition, but not consolidation memory processes in rats. While the focus to enhance cognition by modulating α7nAChRs lies on agonists and positive modulators, antagonists at low doses should provide a novel approach to improve cognition in neurological and psychiatric disorders.

KW - Antagonist

KW - Ligand-gated ion channel

KW - Long-term potentiation

KW - Memory acquisition

KW - Receptor activity

KW - α7 nicotinic acetylcholine receptors

UR - http://www.scopus.com/inward/record.url?scp=85067173813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067173813&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2019.06.003

DO - 10.1016/j.cellsig.2019.06.003

M3 - Article

AN - SCOPUS:85067173813

VL - 62

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

M1 - 109338

ER -